Besides its central role in bile acid metabolism, FXR activation also regulates the expression of various genes involved in glucose, lipid, and lipoprotein metabolism, crucial in NAFLD [223]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.